VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PRLBProto Labs, Inc.
$81.06$1.9B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

PRLB logoProto Labs, Inc.(PRLB)Earnings, Financials & Key Ratios

PRLB•NYSE
92.1× P/E·Price updated Jun 19, 2026
SectorIndustrialsIndustryMetal FabricationSub-IndustryFabrication, machining and tooling
AboutProto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end markets. The company was incorporated in 1999 and is headquartered in Maple Plain, Minnesota.Show more
  • Revenue$533M+6.4%
  • EBITDA$60M-2.1%
  • Net Income$21M+28.0%
  • EPS (Diluted)0.88+33.3%
  • Gross Margin44.48%-0.2%
  • EBITDA Margin11.26%-8.0%
  • Operating Margin4.91%-3.4%
  • Net Margin3.98%+20.3%
  • ROE3.17%+30.3%

PRLB Key Insights

Proto Labs, Inc. (PRLB) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Momentum leader: RS Rating 88 (top 12%)
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Share count reduced 3.8% through buybacks
  • ✓Trading near 52-week high

✗Weaknesses

  • ✗Weak 3Y average ROE of 2.7%
  • ✗Profits declining 16.0% over 5 years

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when PRLB posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PRLB Price & Volume

Proto Labs, Inc. (PRLB) stock price & volume — 10-year historical chart

Loading chart...

PRLB Growth Metrics

Proto Labs, Inc. (PRLB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years7.28%
5 Years4.18%
3 Years2.96%
TTM9.43%

Profit CAGR

10 Years-7.54%
5 Years-16.03%
3 Years-
TTM72.56%

EPS CAGR

10 Years-6.75%
5 Years-14.18%
3 Years-
TTM75.64%

Return on Capital

10 Years9.15%
5 Years3.64%
3 Years3.77%
Last Year3.79%

PRLB Recent Earnings

Proto Labs, Inc. (PRLB) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
May 1, 2026
Metric
Actual
Est
EPS
$0.54+35.0%
$0.40
Rev
$139M+3.0%
$135M
Q1 2026
Feb 6, 2026
Metric
Actual
Est
EPS
$0.44+25.7%
$0.35
Rev
$136M+5.8%
$129M
Q4 2025
Oct 31, 2025
Metric
Actual
Est
EPS
$0.47+20.5%
$0.39
Rev
$135M+4.9%
$129M
Q3 2025
Jul 31, 2025
Metric
Actual
Est
EPS
$0.41+24.2%
$0.33
Rev
$135M+2.3%
$132M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 1, 2026
$0.54vs $0.40+35.0%
$139Mvs $135M+3.0%
Q1 2026Feb 6, 2026
$0.44vs $0.35+25.7%
$136Mvs $129M+5.8%
Q4 2025Oct 31, 2025
$0.47vs $0.39+20.5%
$135Mvs $129M+4.9%
Q3 2025Jul 31, 2025
$0.41vs $0.33+24.2%
$135Mvs $132M+2.3%
Based on last 12 quarters of dataView full earnings history →

PRLB Peer Comparison

Proto Labs, Inc. (PRLB) competitors in Fabrication, machining and tooling — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
SSYS logoSSYSStratasys Ltd.Product Competitor768.66M8.92-6.97-3.73%-21.01%-13.44%0.03
XMTR logoXMTRXometry, Inc.Product Competitor4.7B93.28-76.4625.87%-7.01%-18.81%1.26
MTLS logoMTLSMaterialise N.V.Product Competitor396.34M6.7144.84-3.63%3.72%4.11%0.26
NNDM logoNNDMNano Dimension Ltd.Product Competitor282.43M1.35-0.9977.3%-286.76%-58.69%0.02
PTC logoPTCPTC Inc.Supply Chain13.65B114.7518.8719.18%41.58%33.14%0.36
ADSK logoADSKAutodesk, Inc.Supply Chain40.92B193.8237.0617.53%19.49%49.42%0.90
TKR logoTKRThe Timken CompanySupply Chain9.89B142.3634.640.19%6.76%9.52%0.64
EME logoEMEEMCOR Group, Inc.Supply Chain37.26B836.5929.6816.64%7.52%38.32%0.23

Compare PRLB vs Peers

Proto Labs, Inc. (PRLB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SSYS

Most directly comparable listed peer for PRLB.

Scale Benchmark

vs ADSK

Larger-name benchmark to compare PRLB against a more recognizable public peer.

Peer Set

Compare Top 5

vs SSYS, XMTR, MTLS, NNDM

PRLB Income Statement

Proto Labs, Inc. (PRLB) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
344.49M445.6M458.73M434.39M488.1M488.4M503.88M500.89M533.13M546.26M
Revenue Growth %
15.58%29.35%2.95%-5.3%12.36%0.06%3.17%-0.59%6.44%9.43%
Cost of Goods Sold
150.65M206.92M223.44M216.57M265.41M272.93M281.88M277.69M295.99M301.23M
COGS % of Revenue
43.73%46.44%48.71%49.86%54.38%55.88%55.94%55.44%55.52%-
Gross Profit
193.84M▲ 0%
238.68M▲ 23.1%
235.29M▼ 1.4%
217.83M▼ 7.4%
222.69M▲ 2.2%
215.47M▼ 3.2%
221.99M▲ 3.0%
223.2M▲ 0.5%
237.14M▲ 6.2%
245.03M▲ 0%
Gross Margin %
56.27%53.56%51.29%50.14%45.62%44.12%44.06%44.56%44.48%44.86%
Gross Profit Growth %
16.12%23.13%-1.42%-7.42%2.23%-3.24%3.03%0.54%6.24%-
Operating Expenses
121.62M149.78M155.43M157.99M194.85M188.52M193.61M197.7M210.94M213.48M
OpEx % of Revenue
35.3%33.61%33.88%36.37%39.92%38.6%38.42%39.47%39.57%-
Selling, General & Admin
98.06M121.05M122.74M121.05M150.61M150.3M153.48M156.41M168.13M169.32M
SG&A % of Revenue
28.46%27.16%26.76%27.87%30.86%30.77%30.46%31.23%31.54%-
Research & Development
23.56M28.73M32.69M36.94M44.24M38.22M40.13M41.3M42.81M42.74M
R&D % of Revenue
6.84%6.45%7.13%8.5%9.06%7.83%7.97%8.24%8.03%-
Other Operating Expenses
0000000001000K
Operating Income
72.23M▲ 0%
88.9M▲ 23.1%
79.86M▼ 10.2%
59.84M▼ 25.1%
27.84M▼ 53.5%
26.95M▼ 3.2%
28.38M▲ 5.3%
25.5M▼ 10.2%
26.2M▲ 2.8%
31.55M▲ 0%
Operating Margin %
20.97%19.95%17.41%13.77%5.7%5.52%5.63%5.09%4.91%5.78%
Operating Income Growth %
16.93%23.08%-10.17%-25.07%-53.47%-3.2%5.33%-10.17%2.77%-
EBITDA
90.7M115.65M110.72M92.43M68.33M66.37M65.91M61.3M60.02M56.67M
EBITDA Margin %
26.33%25.95%24.14%21.28%14%13.59%13.08%12.24%11.26%10.37%
EBITDA Growth %
14.45%27.51%-4.26%-16.52%-26.08%-2.86%-0.7%-6.99%-2.1%-3.23%
D&A (Non-Cash Add-back)
18.47M26.75M30.86M32.59M40.49M39.42M37.53M35.81M33.81M25.12M
EBIT
74.44M91.66M81.19M62.95M40.18M-97.88M29.05M24.87M31.06M25.08M
Net Interest Income
01.7M2.1M1.4M200K1M2.2M5.2M02.35M
Interest Income
01.7M2.1M1.4M200K1M3.3M5.4M02.35M
Interest Expense
0000001.1M200K00
Other Income/Expense
2.21M2.76M1.34M3.11M12.35M-124.82M-430K-824K4.86M4.85M
Pretax Income
74.44M▲ 0%
91.66M▲ 23.1%
81.19M▼ 11.4%
62.95M▼ 22.5%
40.18M▼ 36.2%
-97.88M▼ 343.6%
27.95M▲ 128.6%
24.67M▼ 11.7%
31.06M▲ 25.9%
36.39M▲ 0%
Pretax Margin %
21.61%20.57%17.7%14.49%8.23%-20.04%5.55%4.93%5.83%6.66%
Income Tax
22.66M15.07M17.54M12.08M6.81M5.58M10.73M8.08M9.82M10.64M
Effective Tax Rate %
30.44%16.44%21.6%19.19%16.95%-5.71%38.39%32.75%31.62%29.24%
Net Income
51.78M▲ 0%
76.59M▲ 47.9%
63.66M▼ 16.9%
50.87M▼ 20.1%
33.37M▼ 34.4%
-103.46M▼ 410.0%
17.22M▲ 116.6%
16.59M▼ 3.6%
21.24M▲ 28.0%
25.75M▲ 0%
Net Margin %
15.03%17.19%13.88%11.71%6.84%-21.18%3.42%3.31%3.98%4.71%
Net Income Growth %
21.24%47.92%-16.89%-20.09%-34.39%-410.03%116.64%-3.64%28.01%72.56%
Net Income (Continuing)
51.78M76.59M63.66M50.87M33.37M-103.46M17.22M16.59M21.24M25.75M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
1.93▲ 0%
2.81▲ 45.6%
2.35▼ 16.4%
1.89▼ 19.6%
1.21▼ 36.0%
-3.77▼ 411.6%
0.66▲ 117.5%
0.66▲ 0.0%
0.88▲ 33.3%
1.06▲ 0%
EPS Growth %
19.88%45.6%-16.37%-19.57%-35.98%-411.57%117.51%0%33.33%75.64%
EPS (Basic)
1.942.842.371.901.21-3.770.660.660.89-
Diluted Shares Outstanding
26.85M27.28M27.05M26.9M27.65M27.41M26.22M25.21M24.25M24.29M
Basic Shares Outstanding
26.65M26.98M26.87M26.74M27.62M27.41M26.19M25.1M23.92M23.84M
Dividend Payout Ratio
----------

PRLB Balance Sheet

Proto Labs, Inc. (PRLB) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
165M215.36M236.42M242M183.49M186.57M200.66M194.85M233.54M248.58M
Cash & Short-Term Investments
94.13M131.8M160.66M161.69M77.51M80.13M102.8M103.09M128.12M136.28M
Cash Only
36.71M85.05M125.22M127.6M65.93M56.56M83.79M89.07M110.83M123.97M
Short-Term Investments
57.42M46.75M35.44M34.09M11.58M23.57M19.01M14.02M17.3M12.31M
Accounts Receivable
53.34M64.91M57.45M58.42M81.37M80.27M75.08M69.41M81.43M85.55M
Days Sales Outstanding
56.5153.1745.7149.0860.8559.9954.3850.5855.7554.89
Inventory
11.27M10.09M10.07M10.86M13.16M13.58M13.66M12.3M14.4M14.87M
Days Inventory Outstanding
27.3117.7916.4618.3118.118.1617.6816.1717.7617.12
Other Current Assets
0000012.6M9.12M10.05M9.59M11.87M
Total Non-Current Assets
353.73M403.62M437.25M502.2M745.09M615.6M571.69M548.66M526.81M529.99M
Property, Plant & Equipment
166.66M228M275.14M294.92M287.82M279.16M259.24M230.95M215.46M212.31M
Fixed Asset Turnover
2.07x1.95x1.67x1.47x1.70x1.75x1.94x2.17x2.47x2.54x
Goodwill
129.75M128.75M128.75M128.75M400.61M273.99M273.99M273.99M273.99M273.99M
Intangible Assets
17.61M19.85M17.37M14.35M38M31.25M25.58M21.42M18.61M17.53M
Long-Term Investments
37.03M23.58M12.96M59.36M14.34M26.42M8.02M17.77M14.31M53.49M
Other Non-Current Assets
2.67M3.44M3.03M4.83M4.32M4.78M4.86M4.52M4.44M26.16M
Total Assets
517.37M▲ 0%
618.99M▲ 19.6%
673.67M▲ 8.8%
744.2M▲ 10.5%
928.58M▲ 24.8%
802.17M▼ 13.6%
772.35M▼ 3.7%
743.51M▼ 3.7%
760.36M▲ 2.3%
778.57M▲ 0%
Asset Turnover
0.67x0.72x0.68x0.58x0.53x0.61x0.65x0.67x0.70x0.72x
Asset Growth %
24.9%19.64%8.83%10.47%24.78%-13.61%-3.72%-3.73%2.27%6.28%
Total Current Liabilities
42.38M52.73M47.58M50.25M54.9M71.58M49.68M53.27M67M70.72M
Accounts Payable
15.88M17.41M16.8M18.25M25.36M17.36M15.64M15.5M15.1M19.63M
Days Payables Outstanding
38.4730.7127.4530.7534.8823.2120.2520.3818.6320.51
Short-Term Debt
5M00000001.44M1.24M
Deferred Revenue (Current)
0000000000
Other Current Liabilities
12.1M18.13M15.06M11.99M13.7M12.74M15.29M16.55M26.78M69.48M
Current Ratio
3.89x4.08x4.97x4.82x3.34x2.61x4.04x3.66x3.49x3.51x
Quick Ratio
3.63x3.89x4.76x4.60x3.10x2.42x3.76x3.43x3.27x3.30x
Cash Conversion Cycle
45.3540.2534.7236.6444.0754.9351.8246.3754.8851.51
Total Non-Current Liabilities
13.77M24.75M40.3M49.59M45.19M32.94M27.38M20.09M22.48M24.72M
Long-Term Debt
000000001.61M1.38M
Capital Lease Obligations
008.56M9.51M3.6M2.25M3.6M1.92M1.61M4.32M
Deferred Tax Liabilities
6.97M20.16M26.28M33.85M35.89M26.32M18.74M13.56M16.6M61.32M
Other Non-Current Liabilities
6.8M4.59M5.45M6.24M5.71M4.36M5.03M4.61M2.67M4.39M
Total Liabilities
56.15M77.49M87.88M99.85M100.09M104.52M77.06M73.36M89.48M95.44M
Total Debt
5M011.9M13.33M7.44M21.35M5.48M3.52M4.65M2.62M
Net Debt
-31.71M-85.05M-113.32M-114.27M-58.48M-35.2M-78.31M-85.56M-106.17M-121.35M
Debt / Equity
0.01x-0.02x0.02x0.01x0.03x0.01x0.01x0.01x0.00x
Debt / EBITDA
0.06x-0.11x0.14x0.11x0.32x0.08x0.06x0.08x0.05x
Net Debt / EBITDA
-0.35x-0.74x-1.02x-1.24x-0.86x-0.53x-1.19x-1.40x-1.77x-2.14x
Interest Coverage
------26.41x124.36x--
Total Equity
461.21M▲ 0%
541.5M▲ 17.4%
585.79M▲ 8.2%
644.36M▲ 10.0%
828.49M▲ 28.6%
697.65M▼ 15.8%
695.29M▼ 0.3%
670.15M▼ 3.6%
670.87M▲ 0.1%
683.13M▲ 0%
Equity Growth %
21.43%17.41%8.18%10%28.58%-15.79%-0.34%-3.62%0.11%-1.13%
Book Value per Share
17.1819.8521.6623.9629.9625.4526.5126.5827.6728.13
Total Shareholders' Equity
461.21M541.5M585.79M644.36M828.49M697.65M695.29M670.15M670.87M683.13M
Common Stock
27K27K27K27K28K27K26K24K024K
Retained Earnings
224.7M291.46M324.72M362.9M376.73M258.24M256.4M244.41M0248.88M
Treasury Stock
0000000000
Accumulated OCI
-5.23M-8.49M-7.02M-3.42M-16.82M-34.35M-28.01M-27.98M0-23.49M
Minority Interest
0000000000

PRLB Cash Flow Statement

Proto Labs, Inc. (PRLB) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
81.75M122.93M116.05M106.97M55.24M62.08M73.27M77.83M74.5M73.66M
Operating CF Margin %
23.73%27.59%25.3%24.62%11.32%12.71%14.54%15.54%13.97%-
Operating CF Growth %
9.05%50.38%-5.59%-7.83%-48.36%12.38%18.03%6.22%-4.27%-18.66%
Net Income
51.78M76.59M63.66M50.87M33.37M-103.46M17.22M16.59M21.24M25.75M
Depreciation & Amortization
18.47M26.75M30.86M32.59M40.49M39.42M37.53M35.81M33.81M33.19M
Stock-Based Compensation
8.56M10.93M10.78M14.67M19.09M17.55M15.99M17M15.73M11.15M
Deferred Taxes
90K11.94M6.11M7.58M339K-9.5M-7.66M-5.15M2.91M6.85M
Other Non-Cash Items
1.42M-916K396K79K-12.41M119.67M4.62M2.61M241K-483K
Working Capital Changes
1.43M-2.36M4.25M1.18M-25.64M-1.6M5.58M10.97M567K-2.81M
Change in Receivables
-9.93M-6.1M1.85M-91K-20.89M-1.05M4.55M8.96M-12.48M-13.64M
Change in Inventory
-985K-189K60K-662K-2.39M-310K112K1.26M-2.11M-2M
Change in Payables
3.18M1.94M-719K1.49M4.65M1.38M-1.84M480K-333K2.86M
Cash from Investing
-123.97M-63.28M-44.3M-95.47M-94.66M-43.09M-4.55M-13.58M-13.41M-15.27M
Capital Expenditures
-32.63M-87.1M-62.23M-47.01M-34.21M-21.69M-28.12M-9.17M-14.84M-13.58M
CapEx % of Revenue
9.47%19.55%13.57%10.82%7.01%4.44%5.58%1.83%2.78%2.49%
Acquisitions
-110.53M194K00-127.41M000834K834K
Investments
----------
Other Investing
-8.74M-126K-4M-3M04.11M-301K34K0-2.26M
Cash from Financing
9.19M-10.44M-31.62M-10.73M-22.2M-27.92M-41.86M-58.55M-40.37M-17.78M
Debt Issued (Net)
5M-5M0-154K-552K-531K-306K-296K-309K-233K
Equity Issued (Net)
4.19M-5.44M-29.13M-7.13M-17.42M-25.71M-40.12M-56.26M-36.62M-14.77M
Dividends Paid
0000000000
Share Repurchases
-4.41M-12.23M-33.52M-14.69M-23.28M-29.66M-43.95M-60.28M-42.96M-20.82M
Other Financing
00-2.49M-3.44M-4.23M-1.68M-1.44M-2M-3.43M-2.78M
Net Change in Cash
-32.09M▲ 0%
48.34M▲ 250.6%
40.18M▼ 16.9%
2.38M▼ 94.1%
-61.67M▼ 2693.5%
-9.37M▲ 84.8%
27.23M▲ 390.6%
5.28M▼ 80.6%
21.75M▲ 311.9%
41.28M▲ 0%
Free Cash Flow
49.11M▲ 0%
35.83M▼ 27.1%
53.82M▲ 50.2%
59.96M▲ 11.4%
21.03M▼ 64.9%
40.39M▲ 92.0%
45.16M▲ 11.8%
68.66M▲ 52.0%
59.66M▼ 13.1%
65.41M▲ 0%
FCF Margin %
14.26%8.04%11.73%13.8%4.31%8.27%8.96%13.71%11.19%11.97%
FCF Growth %
18.77%-27.06%50.24%11.4%-64.92%92.05%11.8%52.04%-13.11%-13.22%
FCF per Share
1.831.311.992.230.761.471.722.722.462.69
FCF Conversion (FCF/Net Income)
1.58x1.61x1.82x2.10x1.66x-0.60x4.26x4.69x3.51x2.54x
Interest Paid
19K39K14K23K28K101K1.05M136K00
Taxes Paid
19.11M9.97M4M5.65M7.58M19.16M15.89M13.91M00

PRLB Key Ratios

Proto Labs, Inc. (PRLB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
12.31%15.28%11.29%8.27%4.53%-13.56%2.47%2.43%3.17%3.84%
Return on Invested Capital (ROIC)
14.63%15.05%12.9%8.95%3.21%2.82%3.33%3.18%3.42%4.18%
Gross Margin
56.27%53.56%51.29%50.14%45.62%44.12%44.06%44.56%44.48%44.86%
Net Margin
15.03%17.19%13.88%11.71%6.84%-21.18%3.42%3.31%3.98%4.71%
Debt / Equity
0.01x-0.02x0.02x0.01x0.03x0.01x0.01x0.01x0.00x
Interest Coverage
------26.41x124.36x--
FCF Conversion
1.58x1.61x1.82x2.10x1.66x-0.60x4.26x4.69x3.51x2.54x
Revenue Growth
15.58%29.35%2.95%-5.3%12.36%0.06%3.17%-0.59%6.44%9.43%
Related:PRLB Dividend History·PRLB Revenue History·PRLB Price History·PRLB P/E History·PRLB Financial Ratios·PRLB Institutional Holders

PRLB SEC Filings & Documents

Proto Labs, Inc. (PRLB) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Feb 6, 2026·SEC

Material company update

Oct 31, 2025·SEC

Material company update

Oct 3, 2025·SEC

10-K Annual Reports

4
FY 2026

Feb 20, 2026·SEC

FY 2025

Feb 21, 2025·SEC

FY 2024

Feb 16, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 1, 2026·SEC

FY 2025

Oct 31, 2025·SEC

FY 2025

Jul 31, 2025·SEC

PRLB Frequently Asked Questions

Proto Labs, Inc. (PRLB) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Proto Labs, Inc. (PRLB) reported $546.3M in revenue for fiscal year 2025. This represents a 1146% increase from $43.8M in 2009.

Proto Labs, Inc. (PRLB) grew revenue by 6.4% over the past year. This is steady growth.

Yes, Proto Labs, Inc. (PRLB) is profitable, generating $25.8M in net income for fiscal year 2025 (4.0% net margin).

Dividend & Returns

Proto Labs, Inc. (PRLB) has a return on equity (ROE) of 3.2%. This is below average, suggesting room for improvement.

Proto Labs, Inc. (PRLB) generated $65.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in PRLB back in 2009?

Total return calculator · dividends reinvested · 17+ years of data

See returns →

How much would $100/month in PRLB be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →